本页面由Tiger Trade Technology Pte. Ltd.提供服务

Gemini Therapeutics, Inc.

1.35
0.0000
成交量:- -
成交额:8.60万
市值:584.93万
市盈率:-0.13
高:1.35
开:1.35
低:1.35
收:1.35
52周最高:32.50
52周最低:1.35
股本:433.28万
流通股本:113.86万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-10.0468
每股收益(LYR):-17.8060
净资产收益率:-35.38%
总资产收益率:-19.49%
市净率:0.06
市盈率(LYR):-0.08

数据加载中...

2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/10

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/19

重要事件披露

8-K - Current report
2023/03/31

重要事件披露

8-K - Current report
2023/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership